Literature DB >> 28993974

Unique variations and characteristics of iridocorneal endothelial syndrome in China: a case series of 58 patients.

Bo Feng1, Xin Tang2, Hong Chen3, Xia Sun3, Ningli Wang3.   

Abstract

PURPOSE: Iridocorneal endothelial (ICE) syndrome is a rare condition, and unique characteristics in Chinese patients can make diagnosis difficult. Our purpose was to describe the clinical characteristics and variations of ICE syndrome in 58 consecutive Chinese patients.
METHODS: The clinical data of consecutive patients with ICE syndrome who were seen between 2008 and 2011 at the glaucoma clinic of our ophthalmology department were retrospectively reviewed. The diagnostic criteria for ICE syndrome were a "hammered-silver" appearance of the corneal endothelium and specular microscopy showing ICE cells characterized by the absence of a hexagonal appearance, dark areas within the cells, and a light-dark reversal pattern. The general characteristics of the cornea, iris, pupil, and anterior chamber angles were compiled and examined.
RESULTS: Fifty-eight patients with ICE syndrome were identified: 26 had Chandler's syndrome (CS), 23 Cogan-Reese syndrome, and nine progressive iris atrophy (PIA). The incidence of glaucoma was 98%. Twenty-three (39.7%) patients had atypical ICE syndrome. Intraocular pressure was relatively high in 13 patients with slightly damaged irises, while the corneal endothelium remained relatively intact. Slit lamp examination showed an intact iris in ten patients (17.2%), with massive deposition of black pigment in the anterior chamber angle. In the 25 patients in whom the anterior chamber angle was only partially closed, 80% of the anterior chamber angles were hyperpigmented.
CONCLUSIONS: CS is the most common variation of ICE syndrome in Chinese patients, and PIA is the least common. A slight change or an intact iris under slit lamp examination is a characteristic of ICE syndrome.

Entities:  

Keywords:  Chandler’s syndrome; Glaucoma; Iridocorneal endothelial syndrome; Progressive iris atrophy

Mesh:

Year:  2017        PMID: 28993974     DOI: 10.1007/s10792-017-0712-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  41 in total

1.  Ultrasound biomicroscopy of Chinese eyes with iridocorneal endothelial syndrome.

Authors:  M Zhang; J Chen; L Liang; A M Laties; Z Liu
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  The corneal endothelium and the spectrum of essential iris atrophy.

Authors:  D G Campbell; M B Shields; T R Smith
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

3.  Endothelial metaplasia in the iridocorneal endothelial syndrome.

Authors:  D N Howell; T Damms; J L Burchette; W R Green
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-08       Impact factor: 4.799

4.  Iridocorneal endothelial syndrome in a child.

Authors:  Sarwat Salim; M Bruce Shields; David Walton
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2006 Sep-Oct       Impact factor: 1.402

5.  Immunohistochemical pathology of the corneal endothelium in iridocorneal endothelial syndrome.

Authors:  L W Hirst; J Bancroft; K Yamauchi; W R Green
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-04       Impact factor: 4.799

6.  The essential iris atrophies.

Authors:  M B Shields; D G Campbell; R J Simmons
Journal:  Am J Ophthalmol       Date:  1978-06       Impact factor: 5.258

7.  In vivo confocal microscopic characteristics of iridocorneal endothelial syndrome.

Authors:  Christina N Grupcheva; Charles N J McGhee; Simon Dean; Jennifer P Craig
Journal:  Clin Exp Ophthalmol       Date:  2004-06       Impact factor: 4.207

8.  Bilateral iridocorneal endothelial syndrome presented as Cogan-Reese and Chandler's syndrome.

Authors:  R Huna; A Barak; S Melamed
Journal:  J Glaucoma       Date:  1996-02       Impact factor: 2.503

9.  Proliferative endotheliopathy with iris abnormalities. The iridocorneal endothelial syndrome.

Authors:  R C Eagle; R L Font; M Yanoff; B S Fine
Journal:  Arch Ophthalmol       Date:  1979-11

Review 10.  Diagnosis and Management of Iridocorneal Endothelial Syndrome.

Authors:  Marta Sacchetti; Flavio Mantelli; Marco Marenco; Ilaria Macchi; Oriella Ambrosio; Paolo Rama
Journal:  Biomed Res Int       Date:  2015-09-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.